Beth A. Zamboni

Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients

Ninh M. La‐Beck, Beth A. Zamboni, Alberto Gabizón et al. · Cancer Chemotherapy and Pharmacology · 2011 · 119 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Conditional Survival and the Choice of Conditioning Set for Patients With Colon Cancer: An Analysis of NSABP Trials C-03 Through C-07

Beth A. Zamboni, Greg Yothers, Mehee Choi et al. · Journal of Clinical Oncology · 2010 · 115 citations · Full text

Medicine, Oncology, Surgery +17

The Gender Gap in a Surgical Subspecialty

Jennifer R. Grandis, William E. Gooding, Beth A. Zamboni et al. · Archives of Otolaryngology - Head and Neck Surgery · 2004 · 97 citations

Medicine, Otolaryngology, Surgery +13

Plasma, Tumor, and Tissue Disposition of STEALTH Liposomal CKD-602 (S-CKD602) and Nonliposomal CKD-602 in Mice Bearing A375 Human Melanoma Xenografts

William C. Zamboni, Sandra Strychor, Erin Joseph et al. · Clinical Cancer Research · 2007 · 87 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Decreased STAT1 Expression by Promoter Methylation in Squamous Cell Carcinogenesis

Sichuan Xi, Kevin F. Dyer, Mark A. Kimak et al. · JNCI Journal of the National Cancer Institute · 2006 · 86 citations

Medicine, Genetics, Oncology +17